Through base editing, the expression of key proteins that are dysregulated in rare genetic forms of dilated cardiomyopathies (DCM), such as dystrophin in Duchenne muscular dystrophy [17] and Rbm20 [18], can be restored, representing a promising therapeutic concept. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.